tiprankstipranks
Trending News
More News >
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
US Market
Advertisement

Axsome Therapeutics (AXSM) Financial Statements

Compare
2,235 Followers

Axsome Therapeutics Financial Overview

Axsome Therapeutics's market cap is currently $5.79B. The company's EPS TTM is $-0.97; its P/E ratio is ―; Axsome Therapeutics is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Axsome Therapeutics Earnings and Revenue History

Axsome Therapeutics Debt to Assets

Axsome Therapeutics Cash Flow

Axsome Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis